Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

This renewed interest in DB presented Tarsus with an opportunity to reup its efforts to combat a pressing yet often overlooked health condition.

Senate advances RFK Jr.’s HHS bid; NIH deputy abruptly resigns; FDA approves SpringWorks’ genetic disorder drug.

Royalty Pharma is giving Biogen $250 million for its lupus treatment litifilimab, which is currently in Phase 3 development ...

As advertisers pay more for an ever-scarcer supply of ratings points, pharma’s ironclad devotion to TV could finally be in ...

Under the terms of the agreement, Novartis will pay $925 million upfront and up to $2.15 billion, contingent upon achievement ...

Kaiser Permanente has been under the microscope for shortcomings in mental health care, even as it is held in high esteem on the medical side.

New DTC platforms like LillyDirect and PfizerForAll are triggering a paradigm shift in how pharma companies connect with patients.

Weber Shandwick has promoted Kelley Yoder to lead its North America health practice, effective on Friday.

Total headcount fell 1,000, as job reductions more than offset the acquisition of 2,000-strong Flywheel, and the agency group ...

Agencies told to restore public health websites; How Robert F. Kennedy Jr. could revive a dormant task force to scrutinize vaccine safety; CVS Health CEO under close eye from investors.

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.